advancing innovation to save lives

GHTC honors Sen. Blunt, Rep. Rosa DeLauro & developers of child-friendly TB Medicines

GHTC honored Senator Roy Blunt (R-MO) and Congresswoman Rosa DeLauro (D-CT) at its second annual Innovating for Impact Awards, which celebrates US policymakers and partnerships driving progress in global health innovation. GHTC also recognized the partnership that developed and introduced improved child-friendly tuberculosis (TB) medicines.
Learn More

More than 150 signatories join GHTC in calling for R&D to be included in GHSA

More than 150 organizations and individuals from around the world have already signed on to GHTC's petition calling for the inclusion of an R&D action package in the 2019-2024 Global Health Security Agenda (GHSA) framework.
Take Action

Member Spotlight: DNDi

A patient-needs driven, not-for-profit research and development organization, Drugs for Neglected Diseases initiative (DNDi) works to deliver new treatments for neglected diseases, in particular leishmaniasis, human African trypanosomiasis, Chagas disease, specific filarial infections, paediatric HIV, mycetoma, and hepatitis C. Since its inception in 2003, DNDi has delivered eight treatments, including fexinidazole, the first all-oral treatment for sleeping sickness, two fixed-dose antimalarials (ASAQ and ASMQ), sodium stibogluconate and paromomycin (SSG&PM) combination therapy for visceral leishmaniasis in Africa and a pediatric dosage form of benznidazole for Chagas disease.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 30 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more
PATH/Patrick McKern
GHTC report on US global health R&D impact highlighted in BioWorld

In an article exploring global health R&D needs beyond HIV/AIDS, BioWorld cites GHTC's report Saving lives and creating impact, which found nearly 60 percent of US funding for global health R&D is dedicated to HIV/AIDS research. GHTC's Director Kaitlin Christenson is quoted.

PATH/Erin Joel Santos
GHTC, Policy Cures stress importance of all stages of research

GHTC and Policy Cures recently called on the US Government to fund all stages of research—from early, basic research stages to later stage clinical trials—to create global health tools such as vaccines, drugs, diagnostics, microbicides, and devices in a letter-to-the-editor in BMJ.

Learn More
View All News & Events

Community Event

PATH/Julie Jacobson
Innovation, Partnership, and Self-Reliance: Health Policy Lessons from India’s Bihar State
Center for Strategic & International Studies
Learn More

Member Event

Policy Cures Research
Launch of the 2018 G-FINDER report
Policy Cures Research
Learn More
View All Events
PATH/Mike Wang
Research Roundup: UK vaccine center to help fight epidemics, global map of HIV reveals vaccine challenges, and researchers create antibodies to test and treat Zika

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Patrick McKern
Research Roundup: Male birth control one step closer to reality, three-in-one HIV drug launched, and powdered polio vaccine brings new hope

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide